91原创

Skip to content
Join our Newsletter
Nelson Bennett

Nelson Bennett

Nelson Bennett is a veteran journalist with more than three decades of experience in print journalism. He covers resources and energy for BIV.

Recent Work by Nelson

B.C. First Nation threatens legal challenge to Cariboo Gold mine

B.C. First Nation threatens legal challenge to Cariboo Gold mine

Xat艣奴ll聽First Nation聽says Cariboo Gold mine project does not have their consent
'We鈥檙e doing well,' 91原创 port CEO says despite shutdown

'We鈥檙e doing well,' 91原创 port CEO says despite shutdown

Port of 91原创 CEO Peter Xotta addresses Greater 91原创 Board of Trade
B.C. biogas tech company inks agreements in U.S.

B.C. biogas tech company inks agreements in U.S.

Greenlane Renewables expands into American, South American RNG markets
B.C. forest sector prognosis becoming progressively grim

B.C. forest sector prognosis becoming progressively grim

When an annual allowable cut cannot be achieved, data suggests forestry companies cut and run south.
Oil and gas sector, Premier Smith slam federal emissions cap

Oil and gas sector, Premier Smith slam federal emissions cap

Will new federal oil and gas emissions cap harmonize with B.C.鈥檚?
Status quo better than NDP minority, say B.C. business leaders

Status quo better than NDP minority, say B.C. business leaders

Industry groups urge fiscal restraint.
Japan鈥檚 Sumitomo invests in B.C. critical minerals project

Japan鈥檚 Sumitomo invests in B.C. critical minerals project

Sumitomo investing up to $8 million in nickel-magnesium exploration in Cariboo region
Why Daylight Saving Time is like Groundhog Day

Why Daylight Saving Time is like Groundhog Day

NDP government introduced legislation to permanently fix DST five years ago
More than 100 oil tankers through 91原创 port in six months

More than 100 oil tankers through 91原创 port in six months

Port's new tracking system makes for more efficient coordination of marine traffic
Merger to put biotech Jade Biosciences on Nasdaq

Merger to put biotech Jade Biosciences on Nasdaq

Biotech headed by former Chinook Therapeutics executive Tom Frohlich
More work by Nelson >